Related Experiment Video
Updated: Aug 12, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
[The state of antioxidant defense system in patients with multiple gastroduodenal peptic ulcers]
Abstract:
There were examined 32 patients with multiple gastroduodenal ulcers ageing 24-65 yrs (basic group) and 30 patients with gastroduodenal ulcers of conventional size (group of compare). The antioxidant defense system (ADS) state was studied, using analysis of its enzymes (catalase and superoxydismutase) activity, integrating index F was calculated as well. Prominent disorders of the ADS (the catalase activity increase and the superoxydismutase activity decrease) were revealed in patients with multiple gastroduodenal ulcers. Also the reduction of index F, which characterizes the ratio of prooxidant and antioxidant properties of the blood, was noted.
More Related Videos
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease III: Clinical Manifestations and Complications

